Active ingredientNifuroxazideCat. No. P-N059-001CAS 965-52-6Family · Pharmaceutical analytical standards
Nifuroxazide
An intestinal antibacterial of the nitrofuran family, patented in 1966 and taken by mouth, as capsules or a suspension, against acute infectious diarrhoea and colitis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It acts locally in the gut; it has been identified as a possible inhibitor of STAT3, a protein some tumour cells depend on, and it has been the subject of preclinical studies.
Go to the active ingredient →Active ingredientNifuroxazideCat. No. P-N059-001CAS 965-52-6
Pharmacopoeial impurityNifuroxazide EP Impurity DCat. No. P-N059-002CAS 112537-96-9
Pharmacopoeial impurityNifuroxazide EP Impurity ECat. No. P-N059-003
Isotopically labelledNifuroxazide-d4Cat. No. P-N059-005CAS 1188487-83-3
Impurity4-HydroxybenzhydrazideCat. No. P-N059-006CAS 5351-23-5
Impuritym-BromobenzohydrazideCat. No. P-N059-007CAS 39115-96-3No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceNifuroxazide CRSEDQM code Y0000836Family NifuroxazideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.